Brie Elizabeth Alford, NP
Nurse Practitioner · Allen
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
Offices
2 locations · Beacon Behavioral of Texas PA · Access Telecare PLLC
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Brie Elizabeth Alford’s office to ask if they take your plan before you enroll.
Medicaid work
$1,042 in 2018
Medicaid paid $1,042 for 54 billed services this clinician did in 2018, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 54 | $1,042 |
| 2018 | 54 | 1 | 20 | $1,042 |
Drugs they prescribed that Part D paid
$25,387
Pharmacies billed $25,387 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 468) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
450 generic and 18 brand-name prescriptions · $25,387 in drug cost · 36 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 46 | $939 | $20 |
| Aripiprazole | 14 | $319 | $23 |
| Buspirone | 28 | $282 | $10 |
| Trazodone | 47 | $213 | $5 |
| Escitalopram | 24 | $175 | $7 |
See all 13 drugs
| Duloxetine | 46 | $939 | $20 |
| Aripiprazole | 14 | $319 | $23 |
| Buspirone | 28 | $282 | $10 |
| Trazodone | 47 | $213 | $5 |
| Escitalopram | 24 | $175 | $7 |
| Hydroxyzine Pamoate | 22 | $173 | $8 |
| Clonazepam | 31 | $168 | $5 |
| Lamotrigine | 23 | $158 | $7 |
| Bupropion Xl | 14 | $154 | $11 |
| Sertraline | 22 | $138 | $6 |
| Gabapentin | 13 | $119 | $9 |
| Zolpidem | 26 | $73 | $3 |
| Alprazolam | 19 | $53 | $3 |
Year by year
| 2024 | 468 | 65 | 0% (0) | 4% | $25,387 |
| 2023 | 636 | 105 | 0% (0) | 4% | $32,794 |
| 2022 | 984 | 116 | 0% (0) | 4% | $63,527 |
| 2021 | 52 | None | 0% (0) | 0% | $1,002 |
| 2020 | 152 | 16 | 0% (0) | 0% | $7,919 |
| 2019 | 74 | 14 | 0% (0) | None | $6,432 |
| 2018 | 36 | 11 | 0% (0) | None | $1,064 |
| 2017 | 11 | None | 0% (0) | None | $115 |
| 2015 | 103 | 21 | 0% (0) | 21% | $20,650 |
| 2014 | 197 | 30 | 0% (0) | 17% | $30,041 |
| 2013 | 83 | 19 | 0% (0) | 18% | $5,933 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 17 drugs
| Aripiprazole | 39 | $1,544 | $40 |
| Duloxetine | 59 | $1,219 | $21 |
| Prazosin | 26 | $1,001 | $38 |
| Quetiapine | 47 | $702 | $15 |
| Buspirone | 47 | $541 | $12 |
| Hydroxyzine Pamoate | 48 | $457 | $10 |
| Bupropion Xl | 29 | $452 | $16 |
| Trazodone | 41 | $442 | $11 |
| Mirtazapine | 14 | $284 | $20 |
| Sertraline | 16 | $243 | $15 |
| Gabapentin | 25 | $168 | $7 |
| Lamotrigine | 31 | $165 | $5 |
| Risperidone | 18 | $154 | $9 |
| Escitalopram | 27 | $147 | $5 |
| Amitriptyline | 17 | $108 | $6 |
| Fluoxetine | 18 | $94 | $5 |
| Venlafaxine Hcl Er | 13 | $44 | $3 |
2022: 23 drugs
| Vraylar | 21 | $29,490 | $1,404 |
| Latuda | 12 | $18,214 | $1,518 |
| Duloxetine | 104 | $1,700 | $16 |
| Aripiprazole | 58 | $1,467 | $25 |
| Trazodone | 88 | $1,406 | $16 |
| Quetiapine | 53 | $1,061 | $20 |
| Bupropion Xl | 46 | $938 | $20 |
| Divalproex Sodium Er | 11 | $909 | $83 |
| Buspirone | 68 | $776 | $11 |
| Prazosin | 44 | $757 | $17 |
| Hydroxyzine Pamoate | 75 | $714 | $10 |
| Mirtazapine | 43 | $617 | $14 |
| Bupropion Hcl Sr | 11 | $325 | $30 |
| Doxepin | 11 | $249 | $23 |
| Lamotrigine | 50 | $238 | $5 |
| Venlafaxine Hcl Er | 27 | $185 | $7 |
| Gabapentin | 34 | $174 | $5 |
| Sertraline | 19 | $134 | $7 |
| Escitalopram | 22 | $120 | $5 |
| Fluoxetine | 32 | $100 | $3 |
| Risperidone | 17 | $92 | $5 |
| Benztropine Mesylate | 21 | $75 | $4 |
| Pramipexole Dihydrochloride | 13 | $66 | $5 |
2020: 3 drugs
| Buspirone | 19 | $178 | $9 |
| Duloxetine | 11 | $173 | $16 |
| Trazodone | 18 | $150 | $8 |
2015: 1 drug
| Citalopram Hbr | 14 | $67 | $5 |
2014: 6 drugs
| Abilify | 13 | $12,953 | $996 |
| Risperdal Consta | 11 | $10,501 | $955 |
| Buspirone | 13 | $161 | $12 |
| Lorazepam | 29 | $140 | $5 |
| Citalopram Hbr | 27 | $138 | $5 |
| Sertraline | 11 | $68 | $6 |
2013: 1 drug
| Sertraline | 18 | $191 | $11 |
Money from drug and device companies
$247 in 2025
| 2025 | 2 | 2 | None | $247 |
| 2024 | 2 | 3 | None | $54 |
| 2023 | 6 | 10 | None | $159 |
| 2021 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tris Pharma | Dyanavel Xr | $125 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $122 | 1 payment
|
See all 2 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-02 | Caplyta | $122 |
| Tris Pharma | Meals · 2025-09-11 | Dyanavel Xr | $125 |
See earlier years (2024, 2023, 2021)
2024: $54
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $39 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $15 | 1 payment
|
2023: $159
| Takeda Pharmaceuticals U.S.A. | Trintellix | $45 | 3 payments
|
| Iti | Caplyta | $40 | 2 payments
|
| Lundbeck | Rexulti | $38 | 2 payments
|
| Janssen Pharmaceuticals | Spravato | $16 | 1 payment
|
| Abbvie | Vraylar | $13 | 1 payment
|
| Corium | Azstarys | $6 | 1 payment
|
2021: $16
| Janssen Pharmaceuticals | Invega Sustenna | $16 | 1 payment
|
Professional record
- NPI
- 1447546387
- Licence
- AR R81444, NC 255170, TX AP131713
- Trained
- University of Arkansas College of Medicine, 2012
- Group
- Beacon Behavioral of Texas PA · Access Telecare PLLC
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 410 Pierce St Ste 103, Houston, TX, 77002
- NPI first listed
- 2011-06-20
- NPI last updated
- 2022-03-07
- NPI record certified
- 2022-03-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 410 Pierce St Ste 103, Houston, TX, 77002 · 303 Bryant St, Mountain View, CA, 94041 · Medical Center Blvd, Winston Salem, NC, 27157